Impact of Pazufloxacin Pill on PPAR-1, AMPK-1 in Rats with Chronic Alcoholic Liver Injury

MU Zhi-long; REN Shi-cun

doi:10.13422/j.cnki.syfix.2014080146

您当前的位置：

首页 >

文章列表页 >

Impact of Pazufloxacin Pill on PPAR-1, AMPK-1 in Rats with Chronic Alcoholic Liver Injury

更新时间：2024-01-04

- Impact of Pazufloxacin Pill on PPAR-1, AMPK-1 in Rats with Chronic Alcoholic Liver Injury
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 8, Pages: 146-150(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfix.2014080146
  CLC：
- Published：2014
- 稿件说明：
移动端阅览
MU Zhi-long, REN Shi-cun. Impact of Pazufloxacin Pill on PPAR-1, AMPK-1 in Rats with Chronic Alcoholic Liver Injury[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(8): 146-150.
DOI：

MU Zhi-long, REN Shi-cun. Impact of Pazufloxacin Pill on PPAR-1, AMPK-1 in Rats with Chronic Alcoholic Liver Injury[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(8): 146-150. DOI： 10.13422/j.cnki.syfix.2014080146.

摘要

目的：观察帕珠丸对乙醇性肝损伤大鼠肝组织中过氧化物酶体增殖物激活受体α1 （PPAR-α1）及腺苷酸活化蛋白激酶α1（AMPK-α1）表达水平的影响及探讨其对肝脏的保护作用。方法：将78只纯系雄性SD大鼠随机分成正常对照组、模型对照组、联苯双酯组、帕珠丸低、中、高剂量组6组。模型组、联苯双酯组、帕珠丸低、中、高剂量组分别给予56%红星二锅头酒10 mL·kg-1灌胃；正常组给予10 mL·kg-1生理盐水灌胃，每天上午1次，连续灌胃12周，复制乙醇性肝损伤模型。造模成功后，帕珠丸低、中、高剂量组分别给予10 mL·kg-1帕珠丸混悬液灌胃，剂量依次为0.05，0.10，0.20 g·kg-1；联苯双酯组给予10 mL·kg-1联苯双酯滴丸混悬液灌胃，剂量为0.003 g·kg-1；正常对照组、模型对照组分别给予同体积生理盐水灌胃，各组每天上午灌胃1次，连续灌胃3周。检测血清丙氨酸转氨酶（ALT）、天门冬氨酸转氨酶（AST）的活性及甘油三酯（TG）的水平，并检测肝组织中PPAR-α1 mRNA、AMPK-α1 mRNA的表达水平。结果：与正常组比较，模型组大鼠血清肝脏湿重和肝指数以及ALT，AST，TG，均显著升高（P<0.05），模型组大鼠肝组织中PPAR-α1 mRNA，AMPK-α1 mRNA显著降低（P<0.01）。与模型组比较，帕珠丸各剂量组与联苯双酯组肝脏湿重和肝指数及ALT，AST，TG均显著降低（P<0.05）；与模型组比较，帕珠丸各剂量组与联苯双酯组PPAR-α1 mRNA，AMPK-α1 mRNA均显著升高（P<0.05）。结论：帕珠丸可上调肝组织内PPAR-α1 mRNA，AMPK-α1 mRNA的表达，提示该药对乙醇性肝病有一定的保护作用。

Abstract

Objective: To observe the impact of Pazufloxacin pill on alcoholic liver injury in rats with peroxisome proliferators activator receptors alphα 1(PPAR-α1)

AMP acitvated kinase-α1(AMPK-α1) and explore its protective effect on the liver. Method: The 78 inbred male SD rats were randomly divided into normal control group

model group

diphenyl dimethyl bicarboxy late(DDB) group

Pazufloxacin pill low

medium and high dose groups 6 groups. Model group

DDB group

Pazufloxacin pill low

medium and high dose groups were given 56% of the Red Star Erguotou wine 10 mL·kg-1 gavage;given normal saline 10 mL·kg-1

every morning a second consecutive gavage 12 weeks;to copy ethanol-induced liver injury model. After the modeling

Pazufloxacin pills low

medium and high dose groups were given 10 mL·kg-1 Pazufloxacin pill suspension gavage

Doses were 0.05

0.10

0.20 g·kg-1;DDB group was given 10 mL·kg-1suspension drop pills orally

at a dose of 0.003 g·kg-1;normal control group

model control group were given the same volume of saline

administered once a day in each group

continuous gavage three weeks. The serum alanine aminotransferase (ALT)

aspartate aminotransferase (AST) activity and triglyceride (TG) levels were measured

and liver tissue PPAR-α1 mRNA

AMPK-α1 mRNA expression levels were detected. Result: Compared with normal group

model group

serum liver wet weight and liver index and ALT

AST

were significantly increased (P<0.05)

model group rat liver tissue PPAR-α1 mRNA

AMPK-α1 mRNA was significantly lower (P<0.01). Compared with model group

in Pazufloxacin pill each dose group and the DDB group liver wet weight and liver index and ALT

AST

TG levels were significantly lower (P<0.05);Compared with model group

in Pa beads pill each dose group and DDB group PPAR-α1 mRNA

AMPK-α1 mRNA were significantly increased (P<0.05). Conclusion: Pazufloxacin pill can increase the liver tissue PPAR-α1 mRNA

AMPK-α1 mRNA expression.It is pointed that the drugs have a protective effect on treating alcoholic liver disease.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Gegensan on Expressions of NOS, α-SMA, Cx43, TGF-β₁ mRNA and Protein in Penile Smooth Muscle Tissue of Alcoholic ED Rats

Rat Model of Chronic Superficial Gastritis

Related Author

Qing-xue WANG

Qi-qi ZHANG

Chun-yan LIU

Shi-yan LUO

Yi-hui CHAI

REN Shou-zhong

MA Zhi-jian

WANG Ji-hao

Related Institution

Guizhou University of Traditional Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰